Schedule 13G ownership disclosure
Scinai Immunotherapeutics Ltd.
American Depositary Shares, each representing 4,000 Ordinary Shares, no par value · CUSIP: 09073Q203
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- STONE DANIEL E.
Shares: 346,667 · Class: 9.9%
- RK Stone Miami, LLC
Shares: 237,867 · Class: 6.71%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001948744-26-000001
- Form type
- SCHEDULE 13G/A
- Filer
- STONE DANIEL E.
- CIK
- CIK 1948744
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership